-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

BTK Mutations and the Emergence of Treatment Resistance: Changing the CLL Landscape

Sponsor: AbbVie (Pharmacyclics)
Program: Industry Theaters
Saturday, December 9, 2023: 11:30 AM-12:30 PM
Room 5A (San Diego Convention Center)
James P. Dean, MD, PhD, AbbVie
Dean: Pharmacyclics LLC, an AbbVie Company: Current Employment, Current holder of stock options in a privately-held company.
For In-Person Participants Only
See more of: Industry Theaters